Standout Papers

Glioma targeted therapy: insight into future of molecular approaches 2021 2026 2022 2024436
  1. Glioma targeted therapy: insight into future of molecular approaches (2022)
    Keyang Yang, Zhijing Wu et al. Molecular Cancer
  2. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer (2021)
    Hao Zhang, Ziyu Dai et al. Journal of Experimental & Clinical Cancer Research
  3. Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts (2022)
    Yuchen Wang, Hao Zhang et al. Journal of Hematology & Oncology

Immediate Impact

1 by Nobel laureates 51 standout
Sub-graph 1 of 22

Citing Papers

Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
1 intermediate paper

Works of Zeyu Wang being referenced

Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
2022
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
2021 Standout

Author Peers

Author Last Decade Papers Cites
Zeyu Wang 904 827 1314 152 3.2k
Anhua Wu 855 625 1318 129 3.4k
Zhixiong Liu 910 964 1617 115 4.4k
Yu Yao 660 551 1061 111 3.0k
Juan Manuel Sepúlveda-Sánchez 812 708 1174 178 3.8k
Julia Glade Bender 608 735 1465 132 4.3k
Xing Liu 469 726 1568 151 3.4k
Hualiang Xiao 546 450 1740 76 3.1k
Anneleen Daemen 486 513 1777 101 3.9k
Zaoqu Liu 743 1151 1357 139 3.0k
Sandrine Rorive 589 441 1505 98 3.8k

All Works

Loading papers...

Rankless by CCL
2026